Oxybutynin/Pilocarpine

奥昔布宁/毛果芸香碱

Report date: 2022/01/14 13:23:58

Base Information

Drug NameOxybutynin/Pilocarpine
Drug Alias NameOxybutynin-Pilocarpine mixt毛果芸香碱/奥昔布宁pilocarpine/oxybutynin毛果芸香碱奥昔布宁Oxybutynin-Pilocarpine +[12
ClassificationSmall molecules
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsHyperhidrosisUrinary Bladder, Overactive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes RomurtideOxybutynin
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTheravida Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHyperhidrosisUrinary Bladder, Overactive

Other Information

ATC CodeN/A
Related LinksN/A